Literature DB >> 126831

In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.

D P Sengar, A Rashid, J E Harris.   

Abstract

Lymphocytes obtained from uraemic patients maintained on intermittent haemodialysis had a normal ability to respond to and stimulate allogeneic lymphocytes obtained from normal subjects in the mixed lymphocyte culture (MLC) reaction. The response of these uraemic lymphocytes to PHA and pokeweed mitogen (PWN) was also normal. Uraemic plasma from eight out of twenty-six patients studied, however, possessed blocking factor activity which suppressed the MLC reactivity of normal random donors and also the mitogenic response of allogeneic lymphocytes but not of autologous uraemic lymphocytes. The blocking factor activity was attributed to a non-dialysable factor present in the plasma of the patients investigated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126831      PMCID: PMC1538267     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Relationship of blood transfusions to appearance of mixed leukocyte culture blocking factor activity in plasma of uraemic patients and renal allograft recipients.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

2.  Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma.

Authors:  D P Sengar; G Opelz; P I Terasaki
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

3.  In vitro reactivity of human lymphocytes in chronic uraemia: analysis and interpretation.

Authors:  J C Daniels; H Sakai; A R Remmers; H E Sarles; J C Fish; E K Cobb; W C Levin; S E Ritzmann
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

4.  Enhanced reactivity in mixed leukocyte cultures after separation of mononuclear cells on Ficoll-Hypaque.

Authors:  B Bain; K Pshyk
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

5.  The potentiation and inhibition by autologous red cells and platelets of human lymphocyte transformation induced by pokeweed mitogen concanavalin A, mercuric chloride, antigen, and mixed leucocyte culture.

Authors:  S Yachnin
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

6.  In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity.

Authors:  H Huber; D Pastner; P Dittrich; H Braunsteiner
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

7.  A semimicro mixed leukocyte culture test.

Authors:  D P Sengar; P I Terasaki
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

8.  An assessment of the mixed leucocyte reaction in renal failure.

Authors:  M W Elves; M C Israëls; M Collinge
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

9.  The effect of uremic plasma on lymphocyte transformation.

Authors:  M R Silk
Journal:  Invest Urol       Date:  1967-09

10.  Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.

Authors:  W M Newberry; J P Sanford
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

  10 in total
  4 in total

1.  Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vitro.

Authors:  S Ikemoto; T Kishimoto; S Wada; N Hayahara; M Maekawa
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.

Authors:  S R Holdsworth; M G Fitzgerald; C S Hosking; R C Atkins
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

3.  Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Effect of haemo- and peritoneal dialysis on the cell-mediated immune response in chronic uraemia.

Authors:  L Németh; L Gofman; A Karátson; A Hámori
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.